# An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

> **NCT02559232** · — · COMPLETED · sponsor: **Bayer** · enrollment: 247 (actual)

## Conditions studied

- Stroke
- Prevention and Control
- Atrial Fibrillation

## Interventions

- **DRUG:** Direct Oral Anticoagulant (DOAC)

## Key facts

- **NCT ID:** NCT02559232
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02559232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02559232, "An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02559232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*